The latest immunotherapy news and developments
In a groundbreaking study published in Current Molecular Pharmacology, researchers have identified a novel biomarker for…
Results of a study led by researchers at Roswell Park Comprehensive Cancer Center, USA, are…
A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a…
The health of the thymus – a key part of the body’s immune system -…
A drug that harnesses the immune system to attack cancer cells has proved successful in…
A new, highly potent class of immunotherapeutics with unique Velcro-like binding properties can kill diverse…
In what experts are calling a paradigm-shifting landmark study, scientists from The Ohio State University…
The most common type of liver cancer in children, hepatoblastoma, surprisingly appears to contain many…
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute…
Researchers from Mass General Brigham, the Broad Institute of MIT and Harvard, USA, have identified…